DUBLIN, Nov. 26, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/8v9x5q/2016_global_tumor) has announced the addition of the "2016 Global Tumor Marker Testing Market: Supplier Shares by Test, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities" report to their offering.
This new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field.
Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
The companies analyzed in the report include:
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Correlogic Systems/Vermillion
- Decode Genetics
- Enzo Biochem
- Exact Sciences
- Guided Therapeutics
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Wako Pure Chemicals
For more information visit http://www.researchandmarkets.com/research/8v9x5q/2016_global_tumor
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets